Understanding Mounjaro: How Many mg in Mounjaro Pen?

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro is a brand-name tirzepatide injection pen that delivers doses ranging from 2.5 mg to 15 mg per weekly injection. The medication works by activating two hormone pathways—GLP-1 and GIP—to reduce appetite and improve metabolic function. PlexusDx offers compounded tirzepatide as a personalized alternative, allowing dosing flexibility at a flat monthly price.

Mounjaro Pen Dose Strengths and Weekly Injections

Mounjaro pens contain tirzepatide formulated in five distinct milligram strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, and 15 mg. Each pen holds a single weekly dose that you inject subcutaneously—typically in the abdomen, thigh, or upper arm. The standard treatment approach begins at 2.5 mg once weekly for the first four weeks, then increases by 2.5 mg increments every four weeks until reaching your target dose or the maximum of 15 mg weekly.

This stepped titration schedule reduces the risk of gastrointestinal side effects and allows your body to adapt to the medication gradually. Most patients find their effective dose between 7.5 mg and 15 mg weekly, though individual response varies significantly. Your healthcare provider adjusts your dose based on your weight loss progress, tolerance, and metabolic response.

How Tirzepatide Dosage Works in Your Body

Tirzepatide activates two separate hormone receptors: the GLP-1 receptor and the GIP receptor. At lower doses (2.5–5 mg), the medication primarily engages the GLP-1 pathway, suppressing appetite through signals to your brain's hunger centers. As you progress to higher doses (10–15 mg), the GIP receptor becomes increasingly activated, adding metabolic benefits that enhance insulin secretion and reduce fat storage.

Clinical trials show that patients receiving 15 mg tirzepatide weekly experienced an average weight loss of 21% of body weight over 72 weeks—significantly more than those on lower doses. However, higher doses also carry increased risk of nausea, vomiting, and other gastrointestinal effects. Your optimal dose balances maximum weight loss benefit against side effects you can tolerate long-term.

Compounded Tirzepatide vs. Brand-Name Mounjaro Pens

PlexusDx compounded tirzepatide offers a key advantage over branded Mounjaro pens: flexible, personalized dosing without flat per-compound pricing increases. While Mounjaro requires buying specific pen strengths, compounded tirzepatide can be prepared at any milligram concentration your provider prescribes. This customization is especially valuable during titration phases or if you need micro-adjustments for optimal tolerance.

Both compounded and branded tirzepatide contain the same active ingredient manufactured under strict pharmaceutical standards. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, ensuring quality and safety. Your dose may need to go up during treatment, but with PlexusDx, your price stays flat at $289 per month—no hidden increases as your milligram strength rises.

Genetic Factors That Influence Your Tirzepatide Dose

Your genetic makeup influences how effectively tirzepatide works and what dose you may need. PlexusDx Precision Peptide Genetic Test analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to identify your individual receptor responsiveness. Patients with certain genetic variants may achieve significant weight loss at lower doses, while others benefit from advancing to higher doses more aggressively.

The test maps 14 metabolic pathways and 150+ genetic insights related to GLP-1 and GIP signaling, appetite regulation, and fat metabolism. Understanding your genetic peptide profile helps your PlexusDx provider personalize your starting dose and titration schedule—potentially reducing side effects and accelerating results. After your first month of treatment, the Precision Peptide Genetic Test is available as a $99 add-on to optimize your protocol.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of Mounjaro?

Mounjaro treatment starts at 2.5 mg injected once weekly for four weeks. Your provider then increases by 2.5 mg increments every four weeks until reaching your target dose or maximum of 15 mg weekly. PlexusDx follows this same evidence-based titration with compounded tirzepatide, allowing your dose to increase without changing your flat monthly price of $289.

How much weight loss can you expect at different tirzepatide doses?

Average weight loss increases significantly with dose escalation. At 10 mg weekly, patients lose approximately 15–18% of body weight over 72 weeks. At the maximum 15 mg weekly dose, average weight loss reaches 21% of body weight. Individual results depend on diet, exercise, genetics, and metabolic factors—which is why PlexusDx offers genetic testing to personalize your protocol.

Does PlexusDx compounded tirzepatide cost more at higher doses?

No. PlexusDx compounded tirzepatide costs a flat $289 per month regardless of dose strength. Your dose may need to go up, but your price won't. This pricing structure removes financial barriers to reaching your optimal therapeutic dose and is available without insurance across all 50 states.

What side effects are more common at higher tirzepatide doses?

Gastrointestinal side effects—nausea, vomiting, constipation, and diarrhea—occur more frequently at 10–15 mg doses than at 2.5–5 mg doses. Most side effects peak in the first 2–4 weeks after a dose increase, then diminish over 4–8 weeks as your body adjusts. Slower titration schedules can reduce side effect severity while maintaining effective weight loss.

How can genetic testing help me find my ideal tirzepatide dose?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy 025 Mg 05 Ml Pen
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.